NAV: 13 Nov 2024 | ₹19.55 |
Min. SIP amount | Not Supported |
Rating | 2 |
Fund size | ₹162.05Cr |
6M | 1Y | 3Y | All | |
---|---|---|---|---|
Fund returns | NA | 35.3% | 15.8% | 18.0% |
Category average | NA | 54.5% | 19.4% | NA |
Rank with in category | NA | 14 | 10 | NA |
Name | Sector | Instrument | Assets |
---|---|---|---|
Sun Pharmaceutical Industries Ltd. | Healthcare | Equity | 13.65% |
Cipla Ltd. | Healthcare | Equity | 6.74% |
Dr. Reddy's Laboratories Ltd. | Healthcare | Equity | 6.48% |
Apollo Hospitals Enterprise Ltd. | Healthcare | Equity | 5.42% |
Eli Lilly And Co | Healthcare | Forgn. Eq | 5.29% |
Max Healthcare Institute Ltd. | Healthcare | Equity | 5.19% |
Divi's Laboratories Ltd. | Healthcare | Equity | 4.67% |
Lupin Ltd. | Healthcare | Equity | 3.97% |
Aurobindo Pharma Ltd. | Healthcare | Equity | 3.23% |
Novo Nordisk A/S - ADR | Healthcare | Forgn. Eq | 3.05% |
Torrent Pharmaceuticals Ltd. | Healthcare | Equity | 2.72% |
Johnson & Johnson Ltd. | Healthcare | Forgn. Eq | 2.69% |
AbbVie Inc | Healthcare | Forgn. Eq | 2.36% |
Fortis Healthcare Ltd. | Healthcare | Equity | 2.13% |
Merck & Co Inc (US) | Healthcare | Forgn. Eq | 2.02% |
Mankind Pharma Ltd. | Healthcare | Equity | 1.96% |
Glenmark Pharmaceuticals Ltd. | Healthcare | Equity | 1.94% |
Novartis AG | Healthcare | ADS/ADR | 1.61% |
Thermo Fisher Scientific Inc. | Healthcare | Forgn. Eq | 1.59% |
Ipca Laboratories Ltd. | Healthcare | Equity | 1.55% |
Abbott Laboratories | Healthcare | Forgn. Eq | 1.33% |
Laurus Labs Ltd. | Healthcare | Equity | 1.28% |
Danaher Corporation | Healthcare | Forgn. Eq | 1.27% |
Amgen Inc. (USA) | Healthcare | Forgn. Eq | 1.20% |
Syngene International Ltd. | Healthcare | Equity | 1.20% |
Intuitive Surgical Inc. (USA) | Healthcare | Forgn. Eq | 1.18% |
Biocon Ltd. | Healthcare | Equity | 1.17% |
Gland Pharma Ltd. | Healthcare | Equity | 1.08% |
JB Chemicals & Pharmaceuticals Ltd. | Healthcare | Equity | 1.07% |
Ajanta Pharma Ltd. | Healthcare | Equity | 1.06% |
Dr. Lal Pathlabs Ltd. | Healthcare | Equity | 1.00% |
Glaxosmithkline Pharmaceuticals Ltd. | Healthcare | Equity | 0.95% |
Vertex Pharmaceuticals Inc. (USA) | Healthcare | Forgn. Eq | 0.86% |
Suven Pharmaceuticals Ltd. | Healthcare | Equity | 0.86% |
Stryker Corp | Healthcare | Forgn. Eq | 0.84% |
Medtronic | Healthcare | Forgn. Eq | 0.79% |
Narayana Hrudayalaya Ltd. | Healthcare | Equity | 0.71% |
Global Health Ltd. | Healthcare | Equity | 0.69% |
Gilead Sciences Inc. (USA) | Healthcare | Forgn. Eq | 0.66% |
Pfizer Ltd. | Healthcare | Equity | 0.64% |
Becton Dickinson And Co | Healthcare | Forgn. Eq | 0.47% |
Iqvia Holdings | Healthcare | Forgn. Eq | 0.31% |
Agilent Technologies Inc | Healthcare | Forgn. Eq | 0.28% |
Sanofi Consumer Healthcare India Ltd. | Healthcare | Equity | 0.21% |
Moderna Inc | Healthcare | Forgn. Eq | 0.17% |
Illumina Inc. (USA) | Healthcare | Forgn. Eq | 0.14% |
Grail Inc | Healthcare | Forgn. Eq | 0.00% |
Inclusive of GST
Nil
0.005% (from July 1st, 2020)
If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.
Min. for 1st investment | ₹100 |
Min. for 2nd investment onwards | ₹100 |
Min. for SIP | Not Supported |